These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1966974)

  • 1. Early experience of paramagnetic tracers in ultra low magnetic fields.
    Paajanen H
    Acta Radiol Suppl; 1990; 374():81-3. PubMed ID: 1966974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything.
    Koenig SH
    Acta Radiol Suppl; 1990; 374():17-23. PubMed ID: 1966965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton relaxation enhancement of albumin, immunoglobulin G, and fibrinogen labeled with Gd-DTPA.
    Paajanen H; Reisto T; Hemmilä I; Komu M; Niemi P; Kormano M
    Magn Reson Med; 1990 Jan; 13(1):38-43. PubMed ID: 2319934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic field dependence of longitudinal relaxation rates of solutions of various protein-gadolinium3+ chelate conjugates.
    Niemi P; Reisto T; Hemmilä I; Kormano M
    Invest Radiol; 1991 Sep; 26(9):820-4. PubMed ID: 1938292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of nuclear magnetic relaxation dispersion (NMRD) profiles in MRI contrast media development.
    Muller RN; Vander Elst L; Rinck PA; Vallet P; Maton F; Fischer H; Roch A; Van Haverbeke Y
    Invest Radiol; 1988 Sep; 23 Suppl 1():S229-31. PubMed ID: 3198350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the relaxivity of Gd(DTPA)2- to everything else.
    Koenig SH
    Magn Reson Med; 1991 Dec; 22(2):183-90. PubMed ID: 1812344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors determining the proton T1 relaxivity in solutions containing Gd-DTPA.
    Aime S; Nano R
    Invest Radiol; 1988 Sep; 23 Suppl 1():S264-6. PubMed ID: 3198359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates.
    Tilcock C; Ahkong QF; Koenig SH; Brown RD; Davis M; Kabalka G
    Magn Reson Med; 1992 Sep; 27(1):44-51. PubMed ID: 1435209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of pulmonary parenchyma and emboli by paramagnetic and superparamagnetic contrast agents.
    Thakur ML; Vinitski S; Mitchell DG; Consigny PM; Lin S; DeFulvio J; Rifkin M
    Magn Reson Imaging; 1990; 8(5):625-30. PubMed ID: 2082134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and water relaxation properties of proteins labeled with paramagnetic metal chelates.
    Lauffer RB; Brady TJ
    Magn Reson Imaging; 1985; 3(1):11-6. PubMed ID: 3923289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of DTPA analogues derived from piperidine and azepane: potential contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Brechbiel MW
    J Org Chem; 2001 Nov; 66(23):7745-50. PubMed ID: 11701031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for electron paramagnetic resonance and water exchange-rate data for understanding small magnetic resonance imaging contrast agents and their macromolecular complexes.
    Koenig SH
    Invest Radiol; 1994 Jun; 29 Suppl 2():S127-30. PubMed ID: 7928207
    [No Abstract]   [Full Text] [Related]  

  • 14. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of polyaza macrocyclic methylene phosphonate chelates of Gd3+ ions as MRI contrast agents.
    Geraldes CF; Brown RD; Cacheris WP; Koenig SH; Sherry AD; Spiller M
    Magn Reson Med; 1989 Jan; 9(1):94-104. PubMed ID: 2540397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gd-DOTA: characterization of a new paramagnetic complex.
    Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
    Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of acute myocardial infarction in pigs using Gd-DTPA.
    Wikström M; Martinussen HJ; Wikström G; Ericsson A; Nyman R; Waldenström A; Hemmingsson A
    Acta Radiol; 1990 Nov; 31(6):619-24. PubMed ID: 2278789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability constants for Gd3+ binding to model DTPA-conjugates and DTPA-proteins: implications for their use as magnetic resonance contrast agents.
    Sherry AD; Cacheris WP; Kuan KT
    Magn Reson Med; 1988 Oct; 8(2):180-90. PubMed ID: 3210955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
    Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
    Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging.
    Schmiedl U; Brasch RC; Ogan MD; Moseley ME
    Acta Radiol Suppl; 1990; 374():99-102. PubMed ID: 1966977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.